The improvement this year is mainly due to the higher revenue generated from primary healthcare and laboratory services as well as a general reduction in expenses.
Aoxin Q&M Dental Group (SGX:QC7
) is expecting to see a “significant overall improvement” to its results for the 1HFY2024.
To be sure, the group says it is anticipating to see a net profit for the period, compared to a net loss in the corresponding period the year before.
